Insider · CIK 0001689392
Sreelakshmi Kolli
director
Files at ISRG (INTUITIVE SURGICAL INC), ZBH (ZIMMER BIOMET HOLDINGS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ZBH ZIMMER BIOMET HOLDINGS, INC. | AGrant or award Phantom Stock Unitsderivative | +174 | $0.00 | $0 | 7,034 | 10 d ago |
| Jun 30, 2025 | ZBH ZIMMER BIOMET HOLDINGS, INC. | AGrant or award Phantom Stock Unitsderivative | +171 | $0.00 | $0 | 5,221 | Jul 2, 2025 |
| May 29, 2025 | ZBH ZIMMER BIOMET HOLDINGS, INC. | AGrant or award Phantom Stock Unitsderivative | +810 | $0.00 | $0 | 5,050 | Jun 2, 2025 |
| May 29, 2025 | ZBH ZIMMER BIOMET HOLDINGS, INC. | AGrant or award Restricted Stock Unitsderivative | +1,405 | $0.00 | $0 | 5,358 | Jun 2, 2025 |
| May 1, 2025 | ISRG INTUITIVE SURGICAL INC | AGrant or award Restricted Stock Unitsderivative | +531 | $0.00 | $0 | 531 | May 1, 2025 |
| Apr 25, 2025 | ISRG INTUITIVE SURGICAL INC | MOption exercise Common Stock | +739 | $0.00 | $0 | 979 | Apr 25, 2025 |
| Apr 25, 2025 | ISRG INTUITIVE SURGICAL INC | MOption exercise Restricted Stock Unitsderivative | -739 | $0.00 | $0 | 0 | Apr 25, 2025 |
| Mar 31, 2025 | ZBH ZIMMER BIOMET HOLDINGS, INC. | AGrant or award Phantom Stock Unitsderivative | +139 | $0.00 | $0 | 4,229 | Apr 2, 2025 |
| Dec 31, 2024 | ZBH ZIMMER BIOMET HOLDINGS, INC. | AGrant or award Phantom Stock Unitsderivative | +148 | $0.00 | $0 | 4,082 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.